4Filing Date: Jan 13, 2026

Dentsply Sirona (XRAY) 4: HOSEIN CLYDE bought 355 shares of Common Stock at $N/A on 2… (Jan 13, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000818479-26-000032
Total Value$0
Trades1
Insiders1

Transaction Details

HOSEIN CLYDE
Director·Direct
Grant · Acquire
Common Stock
Shares+355.05
Price$0.00
Total Value$0
Shares Owned After41.25K
Transaction DateJan 9, 2026
Footnotes ▸

Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Post-Transaction Holdings

HOSEIN CLYDE · Director
SecuritySharesChange
Common Stock41.25K+355.05 (0.87%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-09 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DENTSPLY SIRONA Inc. (XRAY) CIK: 0000818479 --- Reporting Owner --- Name: HOSEIN CLYDE CIK: 0001230185 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-01-09 | Code: A (Grant or award) Shares: +355.0455 | Price: $0.00 Shares Owned After: 41,252.522 | Ownership: D (Direct) Footnotes: [F1] Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. --- Footnotes (Complete Index) --- F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. --- Signature --- /s/ /s/ Jessica Nielsen Causey, Attorney-in-Fact for Clyde Hosein (2026-01-13)

keid analysis is for reference only and does not constitute investment advice.